Dermata Therapeutics, Inc.
DRMA
Revenue
0.00
0.000.00%
-Assets
5.24M
▲56.80k▲1.10%
3 Months ChangeLiabilities
1.92M
▲546.66k▲39.85%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-17
Form 8-K
ID: 0001654954-24-012031
2024-08-07
Form 8-K
ID: 0001654954-24-010104
2024-08-07
Form 10-Q
ID: 0001654954-24-010103
2024-08-02
Form 8-K
ID: 0001654954-24-009903
2024-06-07
Form 8-K
ID: 0001654954-24-007532
2024-06-05
Form 8-K
ID: 0001654954-24-007369
2024-05-24
Form 8-K
ID: 0001654954-24-006912
2024-05-17
Form 8-K
ID: 0001654954-24-006608
2024-05-15
Form 10-Q
ID: 0001654954-24-006398
2024-05-15
Form 8-K
ID: 0001654954-24-006396